InfuSystem Holdings, Inc. reaffirmed earnings guidance for the full year 2023. For the period, the company expected net revenue growth estimated to be in the range of 8% to 10%, or approximately $118 million to $121 million in net revenues.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.61 USD | -0.90% |
|
-4.06% | -37.29% |
05-20 | InfuSystem Approves $20 Million Share Buyback Plan -- Shares Rise After Hours | MT |
05-20 | Tranche Update on InfuSystem Holdings, Inc.'s Equity Buyback Plan announced on June 30, 2021. | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.29% | 142M | |
-5.81% | 180B | |
-1.63% | 107B | |
-4.14% | 67.04B | |
+13.22% | 45.73B | |
-6.56% | 45.26B | |
+6.13% | 41.86B | |
+19.93% | 31.49B | |
+13.61% | 24.77B | |
-5.36% | 24.5B |
- Stock Market
- Equities
- INFU Stock
- News InfuSystem Holdings, Inc.
- InfuSystem Holdings, Inc. Reaffirms Earnings Guidance for the Full Year 2023